KLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes

Molecular Metabolism

Volumn 6, Issue 11, 2017, Pages 1529-1539

  Nargis, Titli ^a   Kumar, Krishna ^a   Ghosh, Amrit Raj ^a   Sharma, Amit ^b   Rudra, Dipayan ^b   Sen, Debrup ^c   Chakrabarti, Saikat ^a   Mukhopadhyay, Satinath ^d   Ganguly, Dipyaman ^a   Chakrabarti, Partha ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b Institute for Basic Science   (South Korea)

^c VIDYASAGAR COLLEGE   (India)

^d INSTITUTE OF POST GRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

DPP4; KLK5; PBMC; T2DM; Th17 cells

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; DIPEPTIDYL PEPTIDASE IV; INTERLEUKIN 17; KALLIKREIN 5; PROTEINASE; DPP4 PROTEIN, HUMAN; KALLIKREIN; KLK5 PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; CD4+ T LYMPHOCYTE; CELL SURFACE; CELLULAR DISTRIBUTION; COHORT ANALYSIS; COMPUTER MODEL; ELECTROPORATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEGRADATION; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; TH17 CELL; BLOOD; ENZYMOLOGY; GENETICS; MIDDLE AGED;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; DIABETES MELLITUS, TYPE 2; DIPEPTIDYL PEPTIDASE 4; FEMALE; HUMANS; KALLIKREINS; MALE; MIDDLE AGED; TH17 CELLS;

EID: 85030749499     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2017.09.004     Document Type: Article

References (53)

1. Drucker, D.J., The biology of incretin hormones. Cell Metabolism 3 (2006), 153–165.
2. Drucker, D.J., Sherman, S.I., Bergenstal, R.M., Buse, J.B., The safety of incretin-based therapies—review of the scientific evidence. The Journal of Clinical Metabolism & Endocrinology 96 (2011), 2027–2031.
3. Yang, F., Zheng, T., Gao, Y., Baskota, A., Chen, T., Ran, X., et al. Increased plasma DPP4 activity is an independent predictor of the onset of metabolic syndrome in Chinese over 4 years: result from the China national diabetes and metabolic disorders study. PloS One, 9, 2014, e92222.
4. Bruce, B.D., Maria, I.S., James, S.P., Christie, M.B., David, C., Alvaro, V., et al. Low-grade systemic inflammation and the development of type 2 diabetes the atherosclerosis risk in communities study. Diabetes 52 (2003), 1799–1805.
5. Chien, P.L., Seongah, H., Takafumi, S., Alan, R.T., The macrophage at the crossroads of insulin resistance and atherosclerosis. Circulation Research 100 (2007), 1546–1555.
6. Pickup, J.C., Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27 (2004), 813–823.
7. Donath, M.Y., Shoelson, S.E., Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology 11 (2011), 98–107.
8. Ghosh, A.R., Bhattacharya, R., Bhattacharya, S., Nargis, T., Rahaman, O., Duttagupta, P., et al. Adipose recruitment and activation of plasmacytoid dendritic cells fuel metaflammation. Diabetes 65 (2016), 3440–3452.
9. Markus, F., Laura, H., Daniela, C., Afia, N., Jamie, W., Ali, N., et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nature Medicine 15 (2009), 930–939.
10. Sampson, M.J., Davies, I.R., Brown, J.C., Ivory, K., Hughes, D.A., Monocyte and neutrophil adhesion molecule expression during acute hyperglycemia and after antioxidant treatment in type 2 diabetes and control patients. Arteriosclerosis Thrombosis and Vascular Biology 22 (2002), 1187–1193.
11. Kreier, F., Kap, Y.S., Mettenleiter, T.C., van Heijningen, C., van der Vliet, J., Kalsbeek, A., et al. Tracing from fat tissue, liver, and pancreas: a neuroanatomical framework for the role of the brain in type 2 diabetes. Endocrinology 147 (2006), 1140–1147.
12. Maarten, E.T., Mathijs, C.B., Petra, J.P., Saskia, B., Jan Hein, T.W., Roger, K.S., et al. Pancreatic fat content and β-cell function in men with and without type 2 diabetes. Diabetes Care 30 (2007), 2916–2921.
13. Maya, E., Kotas, Ruslan, M., Homeostasis, inflammation, and disease susceptibility. Cell 160 (2015), 816–827.
14. Steven, E.S., Jongsoon, L., Allison, B.G., Inflammation and insulin resistance. Journal of Clinical Investigation 116 (2006), 1793–1801.
15. Gorrell, M.D., Gysbers, V., McCaughan, G.W., CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scandinavian Journal of Immunology 54 (2001), 249–264.
16. Lee, S.A., Kim, Y.R., Yang, E.J., Kwon, E.J., Kim, S.H., Kang, S.H., et al. CD26/DPP4 levels in peripheral blood and t cells in patients with type 2 diabetes mellitus. The Journal of Clinical Endocrinology and Metabolism 98 (2013), 2553–2561.
17. Bengsch, B., Seigel, B., Flecken, T., Wolanski, J., Blum, H.E., Thimme, R., Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26). The Journal of Immunology 188 (2012), 5438–5447.
18. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care Supplement 1 (2013), S67–S74.
19. Kirino, Y., Sei, M., Kawazoe, K., Minakuchi, K., Sato, Y., Plasma dipeptidyl peptidase activity correlates with body mass index and the plasma adiponectin concentration in healthy young people. Endocrine Journal 59 (2012), 949–953.
20. Hofmann, K., Stoffel, W., Tmbase – a database of membrane spanning proteins segments. Biological Chemistry Hoppe-Seyler Journal, 374, 1993, 166 http://www.ch.embnet.org/software/tmbase/TMBASE_doc.html.
21. Krogh, A., Larsson, B., von Heijne, G., Sonnhammer, E.L., Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. Journal of Molecular Biology 305 (2001), 567–580.
22. Tusnady, G.E., Simon, I., The HMMTOP transmembrane topology prediction server. Bioinformatics 17 (2001), 849–850.
23. Kim, D.E., Chivian, D., Baker, D., Protein structure prediction and analysis using the Robetta server. Nucleic Acids Research 32 (2004), W526–W531.
24. Colovos, C., Yeates, T.O., Verification of protein structures: patterns of non-bonded atomic interactions. Protein Science 2 (1993), 1511–1519.
25. Lovell, S.C., Davis, I.W., Arendall, W.B. 3rd, De Bakker, P.I., Word, J.M., Prisant, M.G., et al. Structure validation by Calpha geometry: phi, psi and Cbeta deviation. Proteins 50 (2003), 437–450.
26. Webb, B., Sali, A., Comparative protein structure modelling using modeller. Current protocols in bioinformatics, 2014, John Wiley & Sons, Inc, 10.1002/0471250953.bi0506s47 http://onlinelibrary.wiley.com/doi/10.1002/0471250953.bi0506s47/abstract.
27. Luthy, R., Bowie, J.U., Eisenberg, D., Assessment of protein models with three-dimensional profiles. Nature 356 (1992), 83–85.
28. Bowers, K.J., Chow, E., Xu, H., Dror, R.O., Eastwood, M.P., Gregersen, B.A., et al. Scalable algorithms for molecular dynamics simulations on commodity clusters. Proceedings of the ACM/IEEE Conference on Supercomputing (SC06), Tampa, Florida, 2006.
29. Kaminski, G., Friesner, R.A., Tirado-Rives, J., Jorgensen, W.L., Evaluation and reparameterization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides. The Journal of Physical Chemistry B 105 (2001), 6474–6487.
30. Duhovny, S.D., Inbar, Y., Nussinov, R., Wolfson, H.J., PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Research 33:Web Server issue (2005), W363–W367.
31. Krissinel, E., Henrick, K., Inference of macromolecular assemblies from crystalline state. Journal of Molecular Biology 372 (2007), 774–797.
32. Mannucci, E., Pala, L., Ciani, S., Bardini, G., Pezzatini, A., Sposato, I., et al. Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus. Diabetologia 48 (2005), 1168–1172.
33. Röhrborn, D., Eckel, J., Sell, H., Shedding of dipeptidyl peptidase 4 is mediated by metalloproteases and up-regulated by hypoxia in human adipocytes and smooth muscle cells. FEBS Letters 588 (2014), 3870–3877.
34. + regulatory T cells. The Journal of Biological Chemistry 285 (2010), 7176–7186.
35. Wang, Z., Grigo, C., Steinbeck, J., Hörsten, S.V., Amann, K., Daniel, C., Soluble DPP4 originates in part from bone marrow cells and not from the kidney. Peptides 57 (2014), 109–117.
36. Mulvihill, E.E., Varin, E.M., Gladanac, B., Campbell, J.E., Ussher, J.R., Baggio, L.L., et al. Cellular sites and mechanisms linking reduction of dipeptidyl peptidase-4 activity to control of incretin hormone action and glucose homeostasis. Cell Metabolism 25 (2016), 152–165.
37. Itou, M., Kawaguchi, T., Taniguchi, E., Sata, M., Dipeptidyl peptidase-4: a key player in chronic liver disease. World Journal of Gastroenterology 19 (2013), 2298–2306.
38. Calanna, S., Christensen, M., Holst, J.J., Laferrère, B., Gluud, L.L., Vilsbøll, T., et al. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies. Diabetologia 56 (2013), 965–972.
39. Zheng, T., Baskota, A., Gao, Y., Chen, T., Tian, H., Yang, F., Increased plasma DPP4 activities predict new-onset hyperglycemia in Chinese over a four-year period: possible associations with inflammation. Metabolism 64 (2015), 498–505.
40. Bogdan, M.J., McDonnell, M.E., Shin, H., Rehman, Q., Hasturk, H., Apovian, C.M., et al. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. The Journal of Immunology 186 (2011), 1162–1172.
41. Gonzalez, F.Z., Auguet, T., Aragonès, G., Jurado, E.G., Berlanga, A., Martinez, S., et al. Interleukin-17A gene expression in morbidly obese women. International Journal of Molecular Science 16 (2015), 17469–17481.
42. Winer, S., Paltser, G., Chan, Y., Tsui, H., Engleman, E., Winer, D., et al. Obesity predisposes to Th17 bias. European Journal of Immunology 39 (2009), 2629–2635.
43. Ip, B., Cilfone, N., Belkina, A.C., Furia, J.D., Bogdan, M.J., Zhu, M., et al. Th17 cytokines differentiate obesity from obesity-associated type 2 diabetes and promote TNFα production. Obesity 24 (2016), 102–112.
44. Emamaullee, J.A., Davis, J., Merani, S., Toso, C., Elliott, J.F., Thiesen, A., et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes 58 (2009), 1302–1311.
45. Ferraro, A., Socci, C., Stabilini, A., Valle, A., Monti, P., Piemonti, L., et al. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes 60 (2011), 2903–2913.
46. Pelletier, M., Maggi, L., Micheletti, A., Lazzeri, E., Tamassia, N., Costantini, C., et al. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115 (2010), 335–343.
47. Lizama, A.J., Andrade, Y., Colivoro, P., Sarmiento, J., Matus, C.E., Gonzalez, C.B., et al. Expression and bioregulation of the kallikrein-related peptidases family in the human neutrophil. Innate Immunity 6 (2015), 575–586.
48. Mantovani, A., Cassatella, M.A., Costantini, C., Jaillon, S., Neutrophils in the activation and regulation of innate and adaptive immunity. Nature Reviews Immonology 11 (2011), 519–531.
49. Tesmer, L.A., Lundy, S.K., Sarkar, S., Fox, D.A., Th17 cells in human disease. Immunological Reviews 223 (2008), 87–113.
50. Prassas, I., Eissa, A., Poda, G., Diamandis, E.P., Unleashing the therapeutic potential of human kallikrein-related serine proteases. Nature Reviews Drugs Discovery 14 (2015), 183–202.
51. Lamers, D., Famulla, S., Wronkowitz, N., Hartwig, S., Lehr, S., Ouwens, D.M., et al. Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome. Diabetes 60 (2011), 1917–1925.
52. Makdissi, A., Ghanim, H., Vora, M., Green, K., Abuaysheh, S., Chaudhuri, A., et al. Sitagliptin exerts an antinflammatory action. The Journal of Clinical Endocrinology & Metabolism 97 (2012), 3333–3341.
53. Gupta, V., Kalra, S., Choosing a gliptin. Indian Journal of Endocrinology and Metabolism 15 (2011), 298–308.